Co-evaluation of magnesium and 25-hydroxyvitamin D3 in predicting the severity of COVID-19 disease

Abstract

The severity of COVID-19 disease ranges from asymptomatic to severe, life-threatening symptoms. The aim of our study was to co-evaluate magnesium and 25-hydroxyvitamin D3 in predicting the severity of this disease.This study included 232 inpatients with COVID-19 and 250 healthy individuals (control group). Magnesium and 25-hydroxyvitamin D3 levels were compared. ROC curve analysis was performed by co-evaluation of magnesium and 25-hydroxyvitamin D3 levels. Correlation analysis was performed between co-evaluation of magnesium and 25-hydroxyvitamin D3 levels together and the laboratory parameters used in the prognosis of COVID-19 disease.Magnesium and 25-hydroxyvitamin D3 levels of the group with COVID-19 were lower than the control group (p